Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
6.9
36.26%
80%
—
27x
80%
—
5 Years
Score6.9
Net Growth36.26%
Net Trend80%
Net Income Consistency—
Rev Growth27x
Rev Trend80%
Revenue Consistency—
Foghorn Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 430K to $ 30M and net income went from -$ 68M to -$ 74M. Revenue increased in 4 of those 5 years; net income in 4.
Foghorn Therapeutics Inc currently holds a 5-year HDB Score of 6.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 6.64 | — |
1 Year2025-08-12 | $ 4.87 | 36.34% |
5 Years2021-08-12 | $ 9.82 | -32.38% |
All Time2020-10-23 | $ 18.12 | -63.36% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-10-23 |
|---|---|---|---|---|
| Price | $ 6.64 | $ 4.87 | $ 9.82 | $ 18.12 |
| Return | — | 36.34% | -32.38% | -63.36% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 36M | -$ 64M | $ 167M |
| 2025 | $ 30M | -$ 74M | $ 158M |
| 2024 | $ 22M | -$ 86M | $ 243M |
| 2023 | $ 34M | -$ 98M | $ 234M |
| 2022 | $ 19M | -$ 108M | $ 345M |
| 2021 | $ 1M | -$ 101M | $ 154M |
| IPO2020 | $ 430K | -$ 68M | $ 185M |
Explore beyond FHTX
You're looking at Foghorn Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
